Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle‐aged and older adults: A population‐based cohort study
Authors:
- Eric ManderstedtEMEric Manderstedt
- Bengt ZöllerBZBengt Zöller
- Michael CantorMCMichael Cantor
Open Access
- 9 November 2022
- journal article
- research article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 6 (7) , e12842
Abstract
No abstract availableKeywords
Funding Information
- Vetenskapsrådet
This publication has 36 references indexed in Scilit:
- Tissue factor pathway inhibitor: structure-functionFrontiers in Bioscience-Landmark, 2012
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapyBlood Coagulation & Fibrinolysis, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Total tissue factor pathway inhibitor and venous thrombosisThrombosis and Haemostasis, 2010
- Psychosocial factors and venous thromboembolism: a long‐term follow‐up study of Swedish menJournal of Thrombosis and Haemostasis, 2008
- Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V LeidenBlood Coagulation & Fibrinolysis, 2007
- Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisBlood, 2003
- Blood coagulationThe Lancet, 2000
- Deep Vein Thrombosis and Pulmonary Embolism in the General PopulationArchives of internal medicine (1960), 1997